Can I Have Wilson Disease With Normal Copper Blood Tests? Do I Need a Liver Biopsy?

Being told your ceruloplasmin is normal and your 24-hour urine copper looks fine — but that your doctor still wants to investigate for Wilson disease — is confusing and worrying. You might wonder whether the suspicion even makes sense. It does. Here is why the standard blood and urine tests sometimes miss Wilson disease, and what role a liver biopsy plays in getting to a definitive answer.

Why normal tests do not rule out Wilson disease

Ceruloplasmin and 24-hour urine copper are the most commonly ordered screening tests for Wilson disease, but neither one is perfect. Both can fall within the normal reference range in people who genuinely have the disease, for several reasons.

Ceruloplasmin is an acute-phase reactant: it rises with inflammation, infection, estrogen exposure (including pregnancy and oral contraceptive use), and liver disease from other causes. In a patient whose Wilson disease is presenting primarily as liver disease, co-existing inflammation can push ceruloplasmin into or near the normal range even though copper metabolism is fundamentally disrupted.¹ A 2025 case report documented Wilson disease in a patient who had both normal ceruloplasmin and normal serum copper — two results that, taken at face value, would ordinarily suggest no copper problem at all.²

A 2006 analysis found that a subset of Wilson disease patients with confirmed disease had blood ceruloplasmin in the normal range, reinforcing that this single test cannot be used to exclude the diagnosis.³

24-hour urine copper is more reliable, but it too has limitations. Collection errors are common — an incomplete collection gives a falsely low result. Early or mild disease may not yet produce the dramatic copper excretion typically associated with Wilson disease. The test is also subject to day-to-day biological variation.

The bottom line: if your doctor’s clinical suspicion is based on unexplained liver disease, neuropsychiatric symptoms, a positive family history, or a finding like Kayser-Fleischer rings on slit-lamp examination, normal or borderline routine copper tests do not close the case.⁴

How doctors score the probability of Wilson disease

Rather than relying on any single test, specialists use the Leipzig scoring system — a structured points table developed to combine clinical, biochemical, and genetic evidence into an overall probability estimate.⁴ The score weighs:

Finding	Points
Kayser-Fleischer rings present	+2
Ceruloplasmin below normal	+1 to +2
24-hour urine copper elevated	+1 to +2
Liver copper elevated on biopsy	+1 to +2
Neurological symptoms consistent with WD	+2
Identified ATP7B mutations (one or two)	+1 to +4
Hemolytic anemia with negative Coombs test	+1

A score of 4 or more is considered diagnostic. The important point is that liver biopsy copper content appears directly in the scoring table — it is not a tie-breaker of last resort, it is a routine and planned part of the diagnostic pathway when other results are ambiguous.⁵

What a liver biopsy actually shows

A liver biopsy for Wilson disease diagnosis serves two purposes: it measures hepatic copper concentration directly, and it assesses the degree of liver damage.

Hepatic copper quantification is performed on a core of liver tissue, with results expressed as micrograms of copper per gram of dry liver weight. The diagnostic threshold used by the AASLD 2022 guidance is a figure that most specialist centers work with directly; the key point is that elevated hepatic copper is the most direct available evidence of copper accumulation short of genetic testing.⁵ A 2010 study re-evaluating diagnostic criteria in children with mild liver disease found that hepatic copper measurement improved diagnostic accuracy significantly compared to blood and urine tests alone, especially in patients with early or atypical presentations.⁶

It is important to know that elevated hepatic copper is not unique to Wilson disease — it can occur in primary biliary cholangitis and other cholestatic liver diseases. This is why the Leipzig score combines hepatic copper with other findings rather than treating it as definitive in isolation.

The biopsy also provides histological information: the pattern of liver damage (fatty change, hepatitis, fibrosis, cirrhosis) visible under the microscope gives the specialist important information about the severity and duration of the disease, independent of the copper measurement.

Is a liver biopsy safe?

Liver biopsy is a routine procedure in hepatology, typically performed with ultrasound guidance. The most common complication is mild pain or discomfort at the biopsy site, which resolves within a day or two. Serious complications — significant bleeding requiring transfusion, inadvertent puncture of adjacent structures — are uncommon at experienced centers.⁵

The procedure may carry somewhat higher bleeding risk in patients with liver disease who have reduced clotting factor production. Your hepatologist will check your clotting function before the procedure and may choose a transjugular biopsy approach (through a neck vein rather than through the skin) if standard biopsy is considered higher risk.

When non-invasive tests are enough and when they are not

In clear-cut cases — very low ceruloplasmin, very high urine copper, Kayser-Fleischer rings, and a confirmed ATP7B mutation — the Leipzig score reaches the diagnostic threshold without a biopsy, and many specialists will start treatment without tissue confirmation.⁵

Biopsy becomes most valuable when:

• The routine tests give ambiguous or borderline results (like your situation)
• There are no Kayser-Fleischer rings
• Genetic testing found only one ATP7B variant or a variant of uncertain significance
• The clinical picture includes liver disease of unclear cause that could be Wilson disease or something else
• The doctor needs to know the severity of liver damage to guide treatment decisions

The non-ceruloplasmin-bound copper measurement — sometimes called “free copper” or “exchangeable copper” — is increasingly available as an add-on test that provides more specific information about labile, potentially toxic copper than standard total copper measurements. It may reduce the need for biopsy in some borderline cases as it becomes more widely available.⁷

What happens if the biopsy confirms Wilson disease

If liver copper is elevated and the overall picture points to Wilson disease, treatment begins promptly. Chelation therapy or zinc therapy can begin to remove or block the accumulation of copper, and the liver has a remarkable capacity to recover with appropriate treatment — even in the presence of fibrosis. You can read more about the treatment options at medications overview.

If the biopsy is inconclusive or does not confirm Wilson disease, your specialist will review all the evidence together and consider alternative diagnoses. This is also useful: a biopsy that rules out Wilson disease saves you from a lifetime of unnecessary treatment.

This page is patient education. The decision about whether to proceed with a liver biopsy in your specific case depends on your complete clinical picture and is made by your care team — not by any single test result.

References